Vial sizes available: 2ml, 5ml, 10ml, 20ml, 30ml, 50ml, and 100ml, covering single-dose and higher-volume reconstitution requirements across clinical settings
Although a direct causal link between NAD+ supplementation and cancer progression has not been proven, experts recommend that patients with an ongoing cancer or a history of cancer only consider NAD+ therapy with clearance from their oncologist
Over time, experts found ways to enhance peptide stability
Inconsistent Timing : Taking AOD 9604 at varying times daily reduces effectiveness
Clinical trials would need to assess both hemodynamic parameters and clinical outcomes including walking distance, pain scores, and amputation rates to establish therapeutic benefit